Related Experiment Video
Updated: May 5, 2026
Functional Interrogation of Adult Hypothalamic Neurogenesis with Focal Radiological Inhibition
Published on: November 14, 2013
Requirements for Aurora-A in tissue regeneration and tumor development in adult mammals
Ignacio Pérez de Castro1, Cristina Aguirre-Portolés, Gonzalo Fernández-Miranda
1Authors' Affiliations: Cell Division and Cancer Group; Histopathology Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain; and Department of Genetics and Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina.
Abstract:
Aurora-A is a kinase involved in the formation and maturation of the mitotic spindle and chromosome segregation. This kinase is frequently overexpressed in human cancer, and its activity may confer resistance to antitumoral drugs such as Taxol. Inhibition of Aurora-A results in mitotic defects, and this kinase is considered as an attractive therapeutic target for cancer. Nevertheless, the specific requirements for this kinase in adult mammalian tissues remain unclear. Conditional genetic ablation of Aurora-A in adult tissues results in polyploid cells that display a DNA-damage-like response characterized by the upregulation of p53 and the cell-cycle inhibitor p21(Cip1). This is accompanied by apoptotic, differentiation, or senescence markers in a tissue-specific manner. Therapeutic elimination of Aurora-A prevents the progression of skin and mammary gland tumors. However, this is not due to significant levels of apoptosis or senescence, but because Aurora-A-deficient tumors accumulate polyploid cells with limited proliferative potential. Thus, Aurora-A is required for tumor formation in vivo, and the differential response observed in various tissues might have relevant implications in current therapeutic strategies aimed at inhibiting this kinase in the treatment of human cancer.
Insights
Aurora-A kinase is crucial for tumor formation by maintaining cell proliferation. Inhibiting Aurora-A leads to polyploid cells, halting tumor growth without significant apoptosis, offering new cancer therapy insights.
Area of Science:
- Cell Biology
- Molecular Oncology
- Genetics
Background:
- Aurora-A kinase regulates mitotic spindle formation and chromosome segregation.
- Overexpression of Aurora-A is common in human cancers and linked to drug resistance.
- Aurora-A is a potential therapeutic target for cancer treatment.
Purpose of the Study:
- To investigate the role of Aurora-A in adult mammalian tissues.
- To understand the consequences of Aurora-A inhibition in vivo.
- To evaluate Aurora-A as a therapeutic target in preclinical cancer models.
Main Methods:
- Conditional genetic ablation of Aurora-A in adult mice.
- Analysis of cellular responses including polyploidy, DNA damage response (p53, p21Cip1), apoptosis, differentiation, and senescence.
- Assessment of tumor progression in skin and mammary gland models.
Main Results:
- Genetic ablation of Aurora-A induced polyploid cells with a DNA-damage-like response.
- Tissue-specific induction of apoptosis, differentiation, or senescence markers.
- Therapeutic elimination of Aurora-A prevented tumor progression by accumulating non-proliferative polyploid cells.
Conclusions:
- Aurora-A is essential for tumor formation in vivo.
- Inhibition of Aurora-A leads to polyploidization, limiting tumor cell proliferation.
- Tissue-specific responses to Aurora-A inhibition have implications for cancer therapy strategies.
More Related Videos
12:09A Novel High-resolution In vivo Imaging Technique to Study the Dynamic Response of Intracranial Structures to Tumor Growth and Therapeutics
Published on: June 16, 2013
07:50Utilization of Ultrasound Guided Tissue-directed Cellular Implantation for the Establishment of Biologically Relevant Metastatic Tumor Xenografts
Published on: May 25, 2018
